Fibrinogen Human Withdrawn Phase 3 Trials for Hypofibrinogenemia / Fibrinogen Deficiency Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00916656Fibrinogen Concentrate (Human) − Efficacy and Safety Study